Filter
1864
Text search:
drug
trial
Featured
Recommendations
178
New Publications
320
Language
Document type
No document type
1057
Guidelines
315
Studies & Reports
313
Manuals
80
Strategic & Response Plan
30
Fact sheets
30
Training Material
17
Situation Updates
9
Infographics
5
Resource Platforms
4
Brochures
3
App
1
Countries / Regions
India
95
Global
72
South Africa
55
Western and Central Europe
40
Kenya
29
Africa
29
Uganda
27
Ethiopia
25
Russia
23
Tanzania
22
Eastern Europe
22
Nigeria
21
Zambia
21
Liberia
20
Ukraine
19
Sierra Leone
17
Zimbabwe
17
Latin America and the Carribbean
17
Ghana
15
Nepal
15
Malawi
15
Philippines
14
Bangladesh
13
Rwanda
12
Brazil
12
Myanmar / Burma
11
Colombia
9
South–East Asia Region
9
South Sudan
8
Cambodia
8
Mozambique
8
Namibia
8
East and Southern Africa
8
Asia
8
Germany
7
Indonesia
7
Lesotho
7
West and Central Africa
7
Congo, Democratic Republic of
6
USA
6
Thailand
6
Middle East and North Africa
5
Tajikistan
5
Guinea
4
Argentina
4
Eswatini/ Swaziland
4
Vietnam
4
Senegal
3
Cameroon
3
Syria
3
Sudan
3
Angola
3
Yemen
3
Paraguay
3
Venezuela
3
Laos
3
Georgia
3
Burkina Faso
2
Guinea-Bissau
2
Haiti
2
China
2
North Macedonia
2
Hungary
2
Botswana
2
Bolivia
2
Mexico
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Poland
2
Kyrgyzstan
2
Jamaica
2
Spain
2
Belarus
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Somalia
1
Pakistan
1
Jordan
1
Lebanon
1
Gambia
1
Singapore
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Peru
1
Ecuador
1
Bhutan
1
Armenia
1
Southern Africa
1
Timor Leste/ East Timor
1
Qatar
1
Lithuania
1
Iran
1
Kazakhstan
1
North America
1
Belgium
1
France
1
United Kingdom
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
463
Clinical Guidelines
248
Public Health
92
Women & Child Health
81
Key Resources
26
Pharmacy & Technologies
18
Capacity Building
11
Toolboxes
HIV
285
Mental Health
273
TB
221
COVID-19
127
NTDs
119
NCDs
62
Ebola & Marburg
44
AMR
42
Pharmacy
40
Malaria
39
Caregiver
21
Disability
18
Refugee
18
Planetary Health
15
Rapid Response
12
Health Financing Toolbox
12
Global Health Education
9
Cholera
6
Polio
6
2.0 Rapid Response
6
Conflict
5
Natural Hazards
4
Zika
4
Specific Hazards
3
Social Ethics
3
Accessed on 03.03.2020
Cet article documente le processus de mise en œuvre du Traitement préventif intermittent TPI), une stratégie de prévention du paludisme dont l’administration est couplée au Programme élargi de vaccination (PEV) dans les services de santé, les réactions des prestat
...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1
...
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis
...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th
...
El Programa Nacional de Chagas ha definido la utilización de dos medicamentos para el tratamiento de la Enfermedad de Chagas Crónico Reciente Infantil (en niños de 9 meses a menor de 15 años); el benznidazol (BNZ) que será utilizado como medicamento de primera elección en todos los casos con d
...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-
...
Stories of how people in Georgia, Laos, Sri Lanka, Tajikistan and Vietnam made inclusive development happen in their societies. It contains significant experiences andlessons learnt about the practice of inclusive development for a wide range of excluded or marginalised groups, useful for policy-mak
...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
Pneumonia kills more children than any other illness – more than AIDS, malaria and measles combined. Over 2 million children die from pneumonia each year, accounting for almost 1 in 5 under five deaths worldwide. Yet, little attention is paid to this disease. This joint UNICEF/WHO report examines
...
This Technical Brief reviews current practice and evidence on nutrition-specific preventive approaches to MAM, providing practical guidance for implementers and programme managers, and highlighting gaps in evidence and guidance.
This is the third guidance note in a four-part series of notes related to impact evaluation developed by InterAction with financial support from the Rockefeller Foundation.This third guidance note, Introduction to Mixed Methods in Impact Evaluation, starts by explaining what a mixed methods (MM) imp
...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei
...